Menu
Back to User profile » Dr Zhenning Wang
Papers published by Dr Zhenning Wang:
Palliative Gastrectomy Plus Chemotherapy versus Chemotherapy Alone for Incurable Advanced Gastric Cancer: A Meta-Analysis [Corrigendum]
Wu P, Wang PL, Ma B, Yin SC, Tan YE, Hou WB, Wang ZN, Xu HM, Zhu Z
Cancer Management and Research 2024, 16:71-72
Published Date: 25 January 2024
Palliative Gastrectomy Plus Chemotherapy versus Chemotherapy Alone for Incurable Advanced Gastric Cancer: A Meta-Analysis [Expression of Concern]
Wu P, Wang P, Ma B, Yin S, Tan Y, Hou W, Wang Z, Xu H, Zhu Z
Cancer Management and Research 2023, 15:365-366
Published Date: 18 April 2023
RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum]
Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y
OncoTargets and Therapy 2022, 15:529-530
Published Date: 13 May 2022
Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives
Yong J, Li Y, Lin S, Wang Z, Xu Y
Drug Design, Development and Therapy 2021, 15:2445-2456
Published Date: 9 June 2021
Prognostic Value of Preoperative Fibrinogen for Predicting Clinical Outcome in Patients with Nonmetastatic Colorectal Cancer
Sun Y, Han W, Song Y, Gao P, Yang Y, Yu D, Wang Y, Wang Z
Cancer Management and Research 2020, 12:13301-13309
Published Date: 23 December 2020
Statin use and its potential therapeutic role in esophageal cancer: a systematic review and meta-analysis
Zhou C, Zhong X, Gao P, Wu Z, Shi J, Guo Z, Wang Z, Song Y
Cancer Management and Research 2019, 11:5655-5663
Published Date: 19 June 2019
Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
Wu P, Wang PL, Ma B, Yin SC, Tan YE, Hou WB, Wang ZN, Xu HM, Zhu Z
Cancer Management and Research 2018, 10:4759-4771
Published Date: 26 October 2018
Mechanism of immune evasion in breast cancer
Wang M, Zhang C, Song Y, Wang Z, Wang Y, Luo F, Xu Y, Zhao Y, Wu Z, Xu Y
OncoTargets and Therapy 2017, 10:1561-1573
Published Date: 14 March 2017
RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y
OncoTargets and Therapy 2017, 10:73-83
Published Date: 5 January 2017
Efficacy and safety of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer in first-line and second-line therapies: a meta-analysis
Wang H, Ma B, Gao P, Song Y, Xu Q, Hu Y, Zhang C, Wang Z
OncoTargets and Therapy 2016, 9:5405-5416
Published Date: 30 August 2016
Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis
Chen XW, Zhao JH, Li AL, Gao P, Sun JX, Song YX, Liu JJ, Chen P, Wang ZN
OncoTargets and Therapy 2016, 9:3205-3212
Published Date: 27 May 2016
Long noncoding RNAs in gastric cancer: functions and clinical applications
Wang J, Sun J, Wang J, Song Y, Gao P, Shi J, Chen P, Wang Z
OncoTargets and Therapy 2016, 9:681-697
Published Date: 10 February 2016
Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer
Ma B, Wang J, Song Y, Gao P, Sun J, Chen X, Yang Y, Wang Z
OncoTargets and Therapy 2016, 9:445-453
Published Date: 21 January 2016
Association between promoter polymorphisms of OPN gene and cancer risk: a meta-analysis
Liu JW, He CY, Yuan Q, Wang ZN, Xing CZ, Yuan Y
OncoTargets and Therapy 2016, 9:87-97
Published Date: 30 December 2015
Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers
Sun JX, Song YX, Wang ZN, Wang GL, Gao P, Chen XW, Gao ZH, Xu HM
OncoTargets and Therapy 2014, 7:853-863
Published Date: 28 May 2014